Singapore In Vitro Diagnostic Reagent Industry Outlook 2022 - 2026

See how Singapore In Vitro Diagnostic Reagent performed compared to key markets such as the United States, Germany and the Netherlands.

Key Market Indicators

Export of diagnostic reagents from Singapore is expected to reach $2.1 billion by 2026, up from $1.7 billion in 2021. This represents an annual growth rate of 3.4%. Since 1994, the supply from Singapore has increased by an average of 9.5% each year. In 2021, the UK was the leader in this sector, with exports of $1.7 billion, followed by Germany, the Netherlands, and the UK in second, third, and fourth places respectively. Import of diagnostic reagents in Singapore is projected to reach $896 million by 2026, up from $729 million in 2021. This translates to an annual growth rate of 3.3%. Since 1994, the demand in Singapore has increased by an average of 14.7% each year. In 2021, South Korea was the leader in this field, with imports of $729 million, followed by Germany, China, and the Netherlands in second, third, and fourth places respectively.

Singapore In Vitro Diagnostic Reagent Market Data and Forecasts

How much will Singapore In Vitro Diagnostic Reagent Market grow to 2026?

Forecast: Export of Blood-Grouping Reagents from Singapore

Other Top Countries about In Vitro Diagnostic Reagent